RxDoctor Payments Data

Arpit Aggarwal, DO

Colon & Rectal Surgery · Dearborn, MINPI 1356879035

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (52.5%), travel and lodging and gifts — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Intuitive Surgical at 36.4% of the total. Reporting peaked in 2024 at $2,494 and has fallen 67.3% since, to $816 in 2025.

$5,570in general payments, 2019–2025

Across 64 payments — averaging $87.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$2K
  • Medtronic$2K
  • Johnson & Johnson$1K
  • TELA Bio, Inc.$302
  • Acera Surgical, Inc.$160
  • Davol Inc.$153
  • plus $212 from 3 others

What the payments were for

  • Travel & lodging$2,63847%
  • Food & beverage$2,92352%
  • Gifts$90%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,570 in reported general payments places this provider in the 65th percentile of 72 colon & rectal surgery providers in Michigan.

See all colon & rectal surgery providers in Michigan

Medicare billing

Part B allowed, 2024
$106,980
Medicare patients
223
Services billed
575

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LinzessLinaclotide15$12,747
ErythromycinErythromycin Base15$3,785
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl84$1,411
Lidocaine17$831
Pantoprazole Sodium69$749
Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl39$619
LoperamideLoperamide Hcl16$326
Sucralfate13$310
Metronidazole18$220
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen52$107
Ciprofloxacin Hcl11$72
Metoclopramide Hcl12$55

Paid to pharmacies, not to this prescriber.

Other colon & rectal surgery in Dearborn

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →